Kaewkhao Natpapat, Tarning Joel, Blessborn Daniel
Mahidol Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
Centre for Tropical Medicine & Global Health, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK.
Int J Anal Chem. 2025 Jun 5;2025:5130424. doi: 10.1155/ianc/5130424. eCollection 2025.
Artesunate-amodiaquine (ARS-AQ) is a first-line antimalarial treatment recommended by the World Health Organization. AQ is the long acting partner drug in this combination, and therapeutic success is correlated with the terminal exposure to AQ. Dried blood spot (DBS) sampling for AQ is a convenient and minimally invasive technique, especially suitable for clinical studies in resource limited settings and pediatric studies. Our primary aim was to develop and validate a bioanalytical method for quantification of AQ and its active metabolite in capillary blood applied onto filter paper as a DBS sample. The separation was achieved using a reverse phase column (Zorbax SB-CN 50 × 4.6 mm, I.D. 3.5 μm) and a mobile phase consisting of acetonitrile:ammonium formate 20 mM with 0.5% formic acid (15:85, v/v). A 50 μL DBS was punctured with five 3.2 mm punches from the filter paper, and the punches collected correspond to approximately 15 μL of dried blood. The blood was then extracted using a mixture of 0.5% formic acid in water:acetonitrile (50:50, v/v), along with stable isotope-labeled internal standards (AQ-D10 and desethylamodiaquine [DAQ]-D5). Mass spectrometry was used for quantification over the range of 2.03-459 ng/mL for AQ and 3.13-1570 ng/mL for DAQ. The validation of the method was carried out in compliance with regulatory requirements. The intra- and interbatch precisions were below 15% and passed all validation acceptance criteria. No carryover and no matrix effects were detected. Normalized matrix factors (analyte/internal standard) ranged from 0.96 to 1.03 for all analytes, hence no matrix effects. AQ and DAQ were stable in all conditions evaluated. Long-term stability in DBS samples was demonstrated for up to 10 years when stored at -80°C and for 15 months when stored at room temperature. The developed method was demonstrated to be reliable and accurate. This assay may be particularly useful in the context of resource limited settings and in pediatric field studies.
青蒿琥酯-阿莫地喹(ARS-AQ)是世界卫生组织推荐的一线抗疟治疗药物。阿莫地喹是该联合用药中的长效辅助药物,治疗成功与阿莫地喹的终末暴露量相关。采用干血斑(DBS)采样测定阿莫地喹是一种简便且微创的技术,特别适用于资源有限地区的临床研究和儿科研究。我们的主要目的是开发并验证一种生物分析方法,用于定量测定作为DBS样本涂覆在滤纸上的毛细血管血中阿莫地喹及其活性代谢物的含量。使用反相柱(Zorbax SB-CN 50×4.6 mm,内径3.5μm)和由乙腈:20 mM甲酸铵与0.5%甲酸(15:85,v/v)组成的流动相实现分离。用五个3.2 mm的打孔器从滤纸上对50μL的DBS进行打孔,收集的打孔样本对应约15μL的干血。然后使用0.5%甲酸的水:乙腈(50:50,v/v)混合物以及稳定同位素标记的内标(AQ-D10和去乙基阿莫地喹[DAQ]-D5)对血液进行提取。采用质谱法在2.03 - 459 ng/mL范围内定量测定阿莫地喹,在3.13 - 1570 ng/mL范围内定量测定DAQ。该方法的验证是按照监管要求进行的。批内和批间精密度均低于15%,并通过了所有验证验收标准。未检测到残留和基质效应。所有分析物的归一化基质因子(分析物/内标)范围为0.96至1.03,因此不存在基质效应。阿莫地喹和DAQ在所有评估条件下均稳定。当储存在-80°C时,DBS样本中的长期稳定性长达10年;当储存在室温下时,长达15个月。所开发的方法被证明是可靠且准确的。该测定法在资源有限地区和儿科现场研究中可能特别有用。